The in vitro effects of Pasteurella haemolytica components on bovine pulmonary endothelial monolayers were investigated to determine the relative role of individual bacterial factors in the pathogenesis of bovine pulmonary pasteurellosis. Bovine pulmonary endothelial monolayers were treated with P. haemolytica bacterial culture supernatant (CS) and P. haemolytica lipopolysaccharide. At 22 h postinoculation, the CS produced severe damage to the endothelial cells, indicated by high 5'Cr release, extensive cellular detachment, and morphologic changes characterized by cell contraction, cytoplasmic blebbing, and loss of monolayer confluency. The neutralization of leukotoxin activity of the CS by heat inactivation was ineffective in decreasing the damage to endothelial cells; however, leukotoxin-neutralizing monoclonal antibody slightly diminished the toxic effect. P. haemolytica lipopolysaccharide by itself or as a supplement to CS produced endothelial cell damage similar to that of CS. The preincubation of CS dilutions (10-1 and 10-2) or P. haemolytica lipopolysaccharide with polymyxin B almost completely eliminated cell toxicity. These studies show that P. haemolytica produces a soluble factor that is consistent with bacterial lipopolysaccharide and that is directly toxic to bovine pulmonary endothelial cells in vitro.
Bovine pulmonary pasteurellosis, caused by Pasteurella haemolytica, is one of the most common disease problems in cattle populations. Although stress and predisposing respiratory viruses are important in initiating the pneumonic process, P. haemolytica infection is the major contributor to the pulmonary tissue damage observed in cattle pneumonia (6) .
After colonization of the lung with P. haemolytica, pulmonary tissue damage occurs very rapidly. Five hours after P. haemolytica intrabronchial inoculation, cattle develop severe alveolar and interlobular edema, fibrinous and neutrophilic exudate, pulmonary hemorrhage, and vascular thrombosis (2, 18) . These acute lesions suggest pulmonary endothelial cell damage and subsequent vascular leakage.
The P. haemolytica pathogenic factors that mediate this severe pulmonary tissue damage have not been well defined. A P. haemolytica exotoxin, referred to as leukotoxin, may be an important virulence factor due to lysis of leukocytes and release of tissue-damaging proteases (1) . Although the effect of leukotoxin on nonleukocyte pulmonary cells has not been reported, leukotoxin may have a direct cytotoxic effect on pulmonary endothelial cells, resulting in the vascular damage observed in the disease.
Endotoxin or lipopolysaccharide (LPS) produced by P. haemolytica may also be important in the disease pathogenesis (4) . It has been shown that intravenous inoculation of LPS in sheep incites acute pulmonary inflammation and endothelial cell injury (12) . A similar process could occur in cattle after P. haemolytica pulmonary colonization and release of LPS.
The purpose of this study was to determine whether P. haemolytica soluble components can damage bovine pulmonary endothelial cells in vitro and to identify which bacterial factors are most important in mediating cell damage. By * Corresponding author.
observing the effects of P. haemolytica crude leukotoxin and LPS on bovine pulmonary endothelial monolayers, we have shown that P. haemolytica does produce a soluble factor that is toxic to endothelial cells in vitro. This factor appears to be LPS, as evidenced by effective neutralization with polymyxin B.
MATERIALS AND METHODS
Endothelial cell cultures. Primary endothelial cell cultures were established from pulmonary arteries obtained from a local abattoir by established techniques (16) . Briefly, the arterial intimal surface was gently scraped with a scalpel, and the scraped cells were suspended in Dulbecco modified Eagle medium (DMEM; Whittaker MA Bioproducts, Walkersville, Md.) with 10% Ryan growth supplement (Una Ryan, University of Miami, Miami, Fla.). The cells were grown in tissue culture dishes for 24 to 48 h, and individual endothelial colonies were isolated by using glass cloning rings (Bellco Glass, Inc., Vineland, N.J.) and 0.05% trypsin (GIBCO Laboratories, Grand Island, N.Y.). The cell clones were expanded in tissue culture flasks and identified as endothelial cells by typical cobblestone morphology and the presence of anti-factor VIII antigen as described previously (15) . The endothelial cells used in all experiments were of the same cell line at less than passage 20.
Bacterial factors. Culture supernatant from P. haemolytica in the log phase of growth, referred to as bacterial culture supernatant (CS), was prepared as previously described (17) . Briefly, P. haemolytica (biotype A, serotype 1) was grown on enriched blood agar for 18 h at 37°C, followed by transfer of 7 to 10 bacterial colonies to brain heart infusion broth with 5% fetal bovine serum (FBS). After a 4.5-h incubation at 37°C, the culture was centrifuged at 10,000 x g for 20 min, and the supernatant was discarded. The Data reflect the means and standard errors of the mean of two separate experiments and a minimum of eight experimental wells. There were small but significant differences between the cytotoxic indices of all three groups and a significant difference between the percent detachment of the group treated with CS (b) and the other groups (P < 0.05; Duncan multiple-range test). bated for 90 min at 37°C, and centrifuged at 10,000 x g for 20 min. The supernatant was saved and filtered through a 0.2-,um filter (Costar, Cambridge, Mass.), aliquoted, and stored at -70°C.
The leukotoxin activity of the CS was determined to be 6,855 toxic units per ml by using a previously described neutral red uptake cytotoxicity assay of bovine lymphoma cells (obtained from R. Theilen, University of California, Davis) (8) . The leukocidal activity of a 10-1 dilution of CS was eliminated by either heat denaturation (56°C for 30 min) or incubation for 60 min at 37°C. with leukotoxin-neutralizing monoclonal antibody. The murine monoclonal leukotoxinneutralizing antibody was produced with conventional hybridoma monoclonal techniques. The leukotoxin-neutralizing antibody was characterized as immunoglobulin M. Ascites fluid from mice, implanted with the leukotoxinneutralizing hybridoma clone, was used in these experiments. The neutralization of the leukotoxin with heat inactivation or monoclonal antibody was verified by the neutral red cytotoxicity assay and also by a previously described neutrophil 51Cr release cytotoxicity assay (14) .
The P. haemolytica LPS, extracted from bacteria by phenol-water extraction (11) haemolytica LPS (500 ng/ml) (A), CS (0), CS preincubated with 1,000 U of polymyxin B per ml (C1), P. haemolytica LPS preincubated with 1,000 U of polymyxin B per ml (x), and P. haemolytica LPS preincubated with 1,000 U of polymyxin B per ml (A). The CS and P. haemolytica LPS were both significantly higher than the other three groups at 22 h after treatment (P < 0.05, Duncan multiple-range test). Preincubation with polymyxin B significantly decreased the CS toxic effect and almost completely eliminated the toxic effect of P. haemolytica LPS.
lysate assay (Whittaker MA Bioproducts). An Escherichia coli LPS standard was used to standardize the levels of endotoxin in all bacterial products. The CS contained 104 endotoxin units per ml. To neutralize the endotoxic activity of the CS or P. haemolytica LPS, preparations were incubated for 60 min at 37°C with 1,000 U of polymyxin B (Sigma Chemical Co., St. Louis, Mo.) per ml.
Endothelial cell cytotoxicity assay. Endothelial cell damage was quantified by a previously described 51Cr release assay (10) . Briefly, 105 cells in 1 ml of DMEM-10% RGS were plated into 24-well tissue culture plates. Upon reaching confluency in 24 h, the cells were labeled with 1 ml of 51Cr (10 ,uCi/ml of DMEM-10% Ryan growth supplement; ICN Pharmaceuticals, Irvine, Calif.) for 24 h. The cells were then washed five times with Hanks buffered salt solution, and variables diluted in DMEM-10% FBS were added. The variables tested included CS (10-'), heat-inactivated CS (10-1), CS (10-1) preincubated with neutralizing monoclonal antibody, CS preincubated with polymyxin B, P. haemolytica LPS (diluted in DMEM-10% FBS to equal the level of endotoxin units of CS), and P. haemolytica LPS preincubated with polymyxin B. Dose responses of endothelial cells to CS, P. haemolytica LPS, and E. coli (serotype 055:B5) LPS (Sigma) were also done. At least four wells for each variable were done in each experiment, and experiments were repeated to confirm results. At postinoculation (p.i.) times of 5 and 22 h, the plates were centrifuged, and 200 ,ul of media was removed and measured for 51Cr release with a gamma counter. The cytotoxic index (CI) for each variable was determined using the formula CI = [(A -B)/(C -B)] x 100, where A is the variable release, B is the spontaneous release, and C is the total release. Cellular detachment assay. As a more sensitive indicator of endothelial cell damage, a previously described detachment assay (19) was also used to quantify the degree of endothelial cell membrane damage and decreased adhesion to the culture well plastic surface. The experimental culture wells described above for the 51Cr release assay were used. After removal of the 200 ,ul of medium for the cytotoxicity assay, the wells were washed three times with Hanks buffered salt solution and treated with 500 p,l of 1% Triton X-100. The total content from each well was then measured for 51Cr. The percentage of cellular detachment was computed by the following formula: 100 x [(control -variable)/control].
Morphological observations. At 5 and 22 h p.i. the cell monolayers were observed with an Olympus CK2 inverted phase-contrast microscope.
Statistical analysis. The cytotoxic index and percent cellular detachment for different variables were compared by using the Duncan multiple-range test to determine significant differences (P < 0.05) between groups. RESULTS Effects of P. haemolytica leukotoxin on endothelial cells. P.
haemolytica CS (diluted 10-1 in DMEM-10% heat-inactivated fetal calf serum) produced significant damage to bovine pulmonary endothelial cells, indicated by both 51Cr release (Fig. 1A) and detachment of cells from tissue culture wells (Fig. 1B) Supplemental LPS (ng) FIG. 4 . Cytotoxicity, based on 5"Cr release, of bovine endothelial cells 22 h after the addition of various amounts of P. haemolytica LPS to 10-2 (a), 10-3 (0), and 10-4 (A) dilutions of CS. The data reflect the means and standard errors of the mean for two separate experiments. The addition of P. haemolytica LPS increased the cytotoxic index until a maximum level of toxicity (38 to 42) was reached.
ica LPS had similar levels of 51Cr release ( Fig. 2A ) and cellular detachment (Fig. 2B) . At both 5 and 22 h p.i., the CS and P. haemolytica LPS cytotoxic indices were almost identical. Although there was some variation between the detachment rate of the two groups, the differences were not significant (P < 0.05). The dose responses of P. haemolytica LPS, E. coli LPS, and CS are shown in Fig. 3 the culture supernatant increased damage to endothelial cells (Fig. 4) . When 0.01 ng of LPS was added to dilutions of CS the cytotoxic index increased in the 10-2 and 10-3 CS dilutions but not in the 10-4 dilution. However, the addition of 0.10 ng of LPS elevated the cytocidal index in all three groups, demonstrating that the LPS component of CS was important in mediating endothelial cell injury. A maximum cytocidal index of 39 to 42 was achieved with the addition of 0.10 ng to the 10-2 CS dilution and 10.0 ng to the 10-3 and 10-4 CS dilutions.
Attempts to prevent endothelial cell damage by binding the lipid A portion of the LPS with polymyxin B were variably successful, depending on the concentrations of CS and polymyxin B. Undiluted CS preincubated with 1,000 U of polymyxin B per ml produced cytotoxic indices of 12 at 5 h and 29 at 22 h p.i. (Fig. 2A) . The detachment rate was also significantly decreased in the CS groups treated with polymyxin B (Fig. 2B) . The preincubation of P. haemolytica LPS with polymyxin B almost completely eliminated cell damage, with a cytotoxic index of only 3 and a detachment rate of only 5% at 22 h p.i.
More complete neutralization of the LPS component of the CS was attempted with dilutions of CS and various concentrations of polymyxin B (Fig. 5) . The addition of 100, 200, and 500 U of polymyxin B per ml to either 10-' or 10-2 dilutions of CS produced significant decreases in cytotoxic indices. The culture supernatant dilution of 10-2 produced a cytotoxic index of only 2 after preincubation with 500 U of polymyxin B per ml. However, the addition of 1,000 U of polymyxin B actually raised the cytotoxic index in all Morphological changes in endothelial monolayers. In addition to the 51Cr release and cell detachment, there were corresponding morphological changes in the endothelial cell monolayers compared with control endothelial cells (Fig.  6A) . By 5 h p.i., several degenerative changes were evident in monolayers treated with CS, heat-inactivated CS, CS with leukotoxin-neutralizing monoclonal antibody, and P. haemolytica LPS. These changes were characterized by cell contracture, partial loss of monolayer confluency, and detachment of occasional cells (Fig. 6B) . By 22 h p.i., there were more severe degenerative changes consisting of almost complete loss of confluency, numerous detached shrunken cells, cytoplasmic blebbing, and distortion of remaining attached cells (Fig. 6C) .
The preincubation of crude leukotoxin with polymyxin B prevented some but not all of the cellular degenerative changes. By 22 h p.i., approximately 80 to 90% of the cells were still attached, although occasional cells were contracted and detached (Fig. 6D) (7, 9, 13) . Similar to our results, endothelial cytotoxicity due to E. coli endotoxin is not a rapid change, and 5 to 18 h of incubation is necessary for detectable cytotoxic effects. The morphological changes of cell retraction, cellular protoplasmic blebbing, and cell detachment reported in these previous studies are similar to what we observed in our experiments.
Our results demonstrate that the leukotoxin component of P. haemolytica culture supernatant is not the major component that directly damages endothelial cells. The inactivation of the heat-labile leukotoxin by heat denaturation actually slightly increased the cytotoxic index; however, the detachment rates were similar for both CS and heat-inactivated CS. The preincubation of CS with leukotoxin-neutralizing monoclonal antibody had only a small effect in diminishing the degree of endothelial cell toxicity. This reduction of toxicity by monoclonal antibody may be due to nonspecific interaction of LPS (present in CS) with mouse ascitic fluid, because other nonspecific monoclonal antibodies produce a similar slight decrease of toxicity (Breider, unpublished data) . The importance of leukotoxin in the pathogenesis of pulmonary pasteurellosis should not be completely dismissed, because leukotoxin can effectively kill and lyse bovine leukocytes (1), possibly leading to secondary endothelial cell damage (17) .
The mechanism of direct endotoxin-mediated endothelial cell toxicity is not well defined. Endotoxin may activate the endothelial cells to produce reactive oxygen species such as superoxide radicals, hydrogen peroxide, or hydroxyl radicals, leading to cell membrane damage (9) . In support of this hypothesis, the addition of an oxygen radical scavenger, dimethyl sulfoxide, can prevent endotoxin-mediated damage to endothelial cells in vitro (3) .
In addition to directly damaging bovine endothelial cells, endotoxin may promote pulmonary tissue damage by stimulating an excessive inflammatory response. Endotoxin can induce macrophages in vitro to produce two potent proinflammatory cytokines, interleukin-1 and tumor necrosis factor (5) . The interaction of these cytokines with neutrophils, platelets, and endothelial cells can induce localized hemorrhage, edema, and thrombosis in rabbit models of endotoxemia (5). A similar mechanism of tissue damage may be present in bovine pulmonary pasteurellosis. Endotoxin from intrapulmonary P. haemolytica may cause direct endothelial damage and also initiate interleukin-1 and tumor necrosis factor production by alveolar macrophages, leading to a procoagulant state in the lung. This progression of events could explain the severe vascular thrombosis, hemorrhage, edema, and tissue necrosis usually present in pulmonary pasteurellosis.
To further completely understand the mechanisms leading to P. haemolytica-induced lung injury, other components of the host response need to be investigated. However, the direct toxic effect of P. haemolytica endotoxin on pulmonary endothelial cells appears to be an important factor in pulmonary tissue damage induced by bacteria.
